Tekla Life Sciences Investors (HQL) — Strategic Asset Allocation Index
Tekla Life Sciences Investors (HQL) has a Strategic Asset Allocation Index of 100.2% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $561.89 Million) total $561.89 Million, measured against net assets of $560.83 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Tekla Life Sciences Investors's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Tekla Life Sciences Investors Strategic Asset Allocation Index (2006–2025)
This chart shows how Tekla Life Sciences Investors's Strategic Asset Allocation Index has evolved across 15 annual periods from 2006 to 2025. As of March 2026, the index stands at 100.2%, representing strategic assets of $561.89 Million against net assets of $560.83 Million USD. For live market cap and overall valuation, see Tekla Life Sciences Investors (HQL) total market value.
Annual Strategic Asset Allocation Index for Tekla Life Sciences Investors (2006–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Tekla Life Sciences Investors from 2006 to 2025, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Tekla Life Sciences Investors shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.1% | $514.12 Million | $- | $514.12 Million | $513.66 Million | ▼ 0.0 pp |
| 2024 | 100.1% | $460.30 Million | $- | $460.30 Million | $459.69 Million | ▲ +1.2 pp |
| 2023 | 98.9% | $397.53 Million | $- | $397.53 Million | $401.93 Million | ▼ -5.2 pp |
| 2022 | 104.1% | $414.08 Million | $- | $414.08 Million | $397.90 Million | ▲ +2.0 pp |
| 2021 | 102.0% | $534.01 Million | $- | $534.01 Million | $523.44 Million | ▲ +1.9 pp |
| 2020 | 100.1% | $483.97 Million | $- | $483.97 Million | $483.57 Million | ▲ +0.8 pp |
| 2019 | 99.3% | $381.47 Million | $- | $381.47 Million | $384.16 Million | ▲ +1.2 pp |
| 2018 | 98.1% | $466.45 Million | $- | $466.45 Million | $475.49 Million | ▼ -2.0 pp |
| 2017 | 100.1% | $466.98 Million | $- | $466.98 Million | $466.35 Million | ▲ +10.8 pp |
| 2016 | 89.4% | $370.84 Million | $- | $370.84 Million | $414.97 Million | ▼ -6.5 pp |
| 2015 | 95.9% | $443.83 Million | $- | $443.83 Million | $462.84 Million | ▼ -3.2 pp |
| 2014 | 99.1% | $440.09 Million | $- | $440.09 Million | $444.09 Million | ▼ -0.9 pp |
| 2008 | 100.0% | $277.89 Million | $- | $277.89 Million | $277.80 Million | ▼ -0.2 pp |
| 2007 | 100.3% | $308.77 Million | $- | $308.77 Million | $308.00 Million | ▼ -0.2 pp |
| 2006 | 100.5% | $269.39 Million | $- | $269.39 Million | $268.10 Million | — |